Key Highlights

  • The fund holds 49 U.S. medical equipment companies.
  • Abbott Laboratories and Intuitive Surgical together account for more than 30% of market value.
  • Net asset value is $58.59, after a one-day gain of $1.00, or 1.74%.
  • The expense ratio is 0.37%, with quarterly distributions.

Medical technology continues to draw investor attention, and the iShares U.S. Medical Devices ETF (NYSEARCA:IHI) offers exposure to American manufacturers and distributors of medical equipment in one holding. Figures in this article are current to November 9, 2026. The fund seeks to track an index that includes U.S. equities in the medical devices sector, giving a targeted view of domestic companies that build and distribute medical technology. Shares trade on NYSE Arca and have been listed since May 2006.

Fund Fact

Detail

Exchange and ticker

NYSE Arca: IHI

Fund inception

May 1, 2006

Net assets

$4.06 billion

Net asset value

$58.59

Daily NAV change

+$1.00 (+1.74%)

Expense ratio

0.37%

30-day SEC yield

0.69%

Distribution frequency

Quarterly

Number of holdings

49

Concentration in Leading Device Makers

Abbott Laboratories accounts for about 17.5% of Market Value and Intuitive Surgical about 14.9%. Medtronic, IDEXX Laboratories, Edwards Lifesciences and Becton Dickinson add further weight, with Medtronic at about 11.5%.

The fund’s concentration in its two largest names means developments in surgical robotics, diagnostics or cardiovascular devices can have a noticeable effect on results.

Trading Profile and Price Movement

The net asset value rose $1.00 in the latest session, or 1.74%. Shares outstanding total about 69.4 million, and the 30-day average Volume of roughly 3.9 million shares points to deep liquidity. The median bid-ask spread of 0.02% is narrow.

The premium or discount to NAV stood at -0.03 in recent figures, indicating shares traded almost in line with the value of the underlying holdings.

Costs, Income and Regulatory Factors

The expense ratio is 0.37%, consisting of a management fee of the same amount. Distributions are paid quarterly, and the 30-day SEC Yield of 0.69% reflects a relatively small income component.

Medical device companies face regulatory approvals, product recalls, reimbursement decisions and Patent timelines. These factors shape Earnings across the group and can affect several of the fund’s holdings at the same time.

Final Word

The iShares U.S. Medical Devices ETF provides a concentrated view of American medical equipment producers, led by a small number of large companies. Its liquidity, quarterly distributions and moderate expense ratio shape its practical structure. Investors will weigh the health care theme against their broader sector exposure and time horizon.